Vista Pharmaceuticals has informed that the Company had an USFDA Inspection from 1st February to 9th February, 2018. Form 483 has been issued to the company with observations. The Company will respond to the observations in the next 15 working days.
The above information is a part of company’s filings submitted to BSE.